Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients

计划入组 1,524 人 · 首次发布于 2010 年 3 月 9 日

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

计划入组 510 人 · 首次发布于 2013 年 9 月 2 日

CRISPRoff Epigenetic Editing Enables Durable Gene Silencing in CAR-T Cell Therapy

Breakthrough Epigenetic Editing Platform Enables Safe Multi-Gene Modification in CAR-T Cells

RASAL2 Variant Identified as Novel Biomarker for Anti-EGFR Therapy Resistance in Colorectal Cancer